Prevalence of obesity and overweight in adults and children in Iran; a systematic review

Abstract

BACKGROUND: Obesity is one of the most important underlying risk factors for chronic disease. Dramatically increasing and following complication of obesity should be alerted to health politicians and practitioners to prevent associated health risks. This review aimed to give a better insight into the prevalence of obesity and overweight in different areas of Iran. METHOD: All published internal (SID, Irandoc, Iranmedex), and international (Web of Knowledge, Pubmed, Scopus) source studies, reported the prevalence of overweight/obesity among normal population samples, during Jan 2005 through Jan 2014, were assessed in this review. Paper selection processes were done by two researchers separately. Studies which met the eligible criteria were included in this review. RESULT: One hundred ninety three eligible studies enter into our review. Of 193 final selected studies, 86 (15 national, 71 sub national) of them were reported the prevalence of obesity/overweight in adult, and 107 studies (11 national, 96 sub national) in under-18 by individual. The range of overweight and obesity prevalence in national studies in adult, was 27.0-38.5 (95% CI: 26.8-27.1, 37.2-39.8), and 12.6-25.9 (95% CI: 12.2-13.0, 24.9-26.8), separately. In under-18 the range of overweight and obesity prevalence in national studies were 5.0-13.5 (95% CI: 4.5-5.5, 13.4-13.6), and 3.2-11.9 (95% CI: 3.0-3.4, 11.3-12.4). CONCLUSION: Obesity as an important public health problem has been discussed in recent few decades worldwide. Although the national reported prevalence of obesity in Iran was not considerably diverse, but remarkable differences were seen in the sub national prevalence which must be noticed more in political health programs especially among women and children.

Shown for reading. Its publisher allows quoting it, not republishing it.

References 220

1. 1.

   Ayatollahi S, Ghoreshizadeh Z. Prevalence of obesity and overweight among adults in Iran. Obes Rev. 2010;11(5):335-337.

   Not in our library10.1111/j.1467-789x.2010.00725.x

2. 2.

   Janghorbani M, Amini M, Willett WC, Gouya MM, Delavari A, Alikhani S. First nationwide survey of prevalence of overweight, underweight, and abdominal obesity in Iranian adults. Obesity. 2007;15(11):2797-2808.

   Not in our library10.1038/oby.2007.332

3. 3.

   Marinou K, Tousoulis D, Antonopoulos AS, Stefanadi E, Stefanadis C. Obesity and cardiovascular disease: from pathophysiology to risk stratification. Int J Cardiol. 2010;138(1):3-8.

   Not in our library10.1016/j.ijcard.2009.03.135

4. 4.

   Gill T. Epidemiology and health impact of obesity: an Asia Pacific perspective. Asia Pac J Clin Nutr. 2006;15(Suppl):3-14.

   Not in our library

5. 5.

   Organization WH. Obesity and Overweight. Fact Sheet No. 311. 2006.

   Not in our library

6. 6.

   Kelishadi R. Childhood overweight, obesity, and the metabolic syndrome in developing countries. Epidemiol Rev. 2007;29(1):62-76.

   Not in our library10.1093/epirev/mxm003

7. 7.

   Carreira H, Pereira M, Azevedo A, Lunet N. Trends of BMI and prevalence of overweight and obesity in Portugal (1995–2005): A systematic review. Public Health Nutr. 2012;15(6):972-981.

   Not in our library10.1017/s1368980012000559

8. 8.

   Hasani-Ranjbar S, Nayebi N, Larijani B, Abdollahi M. A systematic review of the efficacy and safety of herbal medicines used in the treatment of obesity. World J Gastroenterol. 2009;15(25):3073.

   Not in our library10.3748/wjg.15.3073

9. 9.

   Tee E. Obesity in Asia: prevalence and issues in assessment methodologies. Asia Pac J Clin Nutr. 2002;11(s8):S694-S701.

   Not in our library10.1046/j.1440-6047.11.s8.12.x

10. 10.

    Lal A, Moodie M, Ashton T, Siahpush M, Swinburn B. Health care and lost productivity costs of overweight and obesity in New Zealand. Aust N Z J Public Health. 2012;36(6):550-556.

    Not in our library10.1111/j.1753-6405.2012.00931.x

11. 11.

    Hasani-Ranjbar S, Amoli MM, Tabatabaei-Malazy O, Rumi Y, Tavakkoly-Bazzaz J, Samimi H, Abbasifarid E. Effect of adiponectin gene polymorphisms on waist circumference in patients with diabetes. J Diabetes Metab Disord. 2012;11(1):14.

    Not in our library10.1186/2251-6581-11-14

12. 12.

    Tabatabaei-Malazy O, Hasani-Ranjbar S, Amoli MM, Heshmat R, Sajadi M, Derakhshan R, Amiri P, Namakchian M, Rezazadeh E, TavaKkoly-Bazzaz J, Keshtkar A, Larijani B. Gender-specific differences in the association of adiponectin gene polymorphisms with body mass index. Review Diabetic Stud. 2010;7(3):241.

    Not in our library10.1900/rds.2010.7.241

13. 13.

    Bazzaz JT, Shojapoor M, Nazem H, Amiri P, Fakhrzadeh H, Heshmat R, Parvizi M, Hasani Ranjbar S, Amoli MM. Methylenetetrahydrofolate reductase gene polymorphism in diabetes and obesity. Mol Biol Rep. 2010;37(1):105-109.

    Not in our library10.1007/s11033-009-9545-z

14. 14.

    Ezzati M, Lopez AD, Rodgers A, Vander Hoorn S, Murray CJ. Selected major risk factors and global and regional burden of disease. Lancet. 2002;360(9343):1347-1360.

    Not in our library10.1016/s0140-6736(02)11403-6

15. 15.
    Rising Burden of Obesity in Asia · 2010

    No notice
16. 16.

    Payab M, Hasani-Ranjbar S, Larijani B. Whether all obese subjects both in metabolic groups and non-metabolic groups should be treated or not. J Diabetes Metabolic Disord. 2014;13(1):21.

    Not in our library10.1186/2251-6581-13-21

17. 17.
    A systematic review of anti-obesity medicinal plants - an update · 2013

    No notice
18. 18.

    Mohammad K, Larijani B. A systematic review of the antioxidant, anti-diabetic, and anti-obesity effects and safety of triphala herbal formulation. J Med Plants Res. 2013;7(14):831-844.

    Not in our library

19. 19.
    Overweight and Obesity in Eastern Mediterranean Region: Prevalence and Possible Causes · 2011

    No notice
20. 20.

    Low S, Chin MC, Deurenberg-Yap M. Review on epidemic of obesity. Ann Acad Med Singap. 2009;38(1):57.

    Not in our library

21. 21.

    Bahreini N, Noor MI, Koon PB, Talib RA, Lubis SH, Dashti MG, Salehi-Abarghouei A, Esmeilzadeh A. Weight status among Iranian adolescents: Comparison of four different criteria. J Res Med Sci. 2013;18(8):641.

    Not in our library

22. 22.

    Azizi F, Azadbakht L, Mirmiran P. Trends in overweight, obesity and central fat accumulation among Tehranian adults between 1998–1999 and 2001–2002: Tehran lipid and glucose study. Ann Nutr Metab. 2005;49(1):3-8.

    Not in our library10.1159/000084171

23. 23.

    Kelly T, Yang W, Chen C, Reynolds K, He J. Global burden of obesity in 2005 and projections to 2030. Int J Obes. 2008;32(9):1431-1437.

    Not in our library10.1038/ijo.2008.102

24. 24.

    Ogden CL, Statistics NCfH. Prevalence of obesity in the United States, 2009–2010. NCHS Data Brief, no 82. 2012.

    Not in our library

25. 25.

    Gutiérrez-Fisac J, Guallar-Castillón P, León-Muñoz L, Graciani A, Banegas J, Rodríguez-Artalejo F. Prevalence of general and abdominal obesity in the adult population of Spain, 2008–2010: the ENRICA study. Obes Rev. 2012;13(4):388-392.

    Not in our library10.1111/j.1467-789x.2011.00964.x

26. 26.

    Delibasi T, Karaaslan Y, Ustun I, Koroglu E, Hosgor S. National prevalence of underweight, overweight and obesity in Turkey: cross sectional study of a representative adult population. Central European J Med. 2007;2(3):294-303.

    Not in our library

27. 27.

    Jafar TH, Chaturvedi N, Pappas G. Prevalence of overweight and obesity and their association with hypertension and diabetes mellitus in an Indo-Asian population. Can Med Assoc J. 2006;175(9):1071-1077.

    Not in our library10.1503/cmaj.060464

28. 28.

    Ogden CL, Carroll MD, Kit BK, Flegal KM. Prevalence of childhood and adult obesity in the United States, 2011–2012. JAMA. 2014;311(8):806-814.

    Not in our library10.1001/jama.2014.732

29. 29.

    Statistics NCfH. Health, United States, 2011: With Special Feature on Socioeconomic Status and Health. 2012.

    Not in our library

30. 30.

    Oh K, Jang MJ, Lee NY, Moon JS, Lee CG, Yoo MH, Kim YT. Prevalence and trends in obesity among Korean children and adolescents in 1997 and 2005. Korean J Pediatrics. 2008;51(9):950-955.

    Not in our library10.3345/kjp.2008.51.9.950

31. 31.

    Dobson AJ, Evans A, Ferrario M, Kuulasmaa KA, Moltchanov VA, Sans S, Tunstall-Pedoe H, Tuomilehto JO, Wedel H, Yarnell J. Changes in estimated coronary risk in the 1980s: data from 38 populations in the WHO MONICA Project. Ann Med. 1998;30(2):199-205.

    Not in our library10.3109/07853899808999404

32. 32.

    Kelishadi R, Mohammadifard N, Sarrazadegan N, Nouri F, Pashmi R, Bahonar A, Heidari H, Asgari S, Boshtam M, Mardani A. The effects of a comprehensive community trial on cardiometabolic risk factors in adolescents: Isfahan Healthy Heart Program. ARYA Atherosclerosis. 2012;7(4):184-190.

    Not in our library

33. 33.

    Barzin M, Hosseinpanah F, Saber H, Sarbakhsh P, Nakhoda K, Azizi F. Gender differences time trends for metabolic syndrome and its components among Tehranian children and adolescents. Cholesterol. 2012;2012:6.

    Not in our library10.1155/2012/804643

34. 34.

    Motlagh ME, Kelishadi R, Ziaoddini H, Mirmoghtadaee P, Poursafa P, Ardalan G, Dashti M, Aminaee T. Secular trends in the national prevalence of overweight and obesity during 2007–2009 in 6-year-old Iranian children. J Res Med Sci. 2011;16(8):979.

    Not in our library

35. 35.

    Heshmat R, Khashayar P, Meybodi H, Homami MR, Larijani B. The appropriate waist circumference cut-off for Iranian population. Acta Med Indones. 2010;42(4):209-215.

    Not in our library

36. 36.

    Nuri R, Moghadasi M, Moraveji F. Association between Obesity and Overweight with Lifestyle Status and Physical Fitness Level in Shiraz Adults. Iran J Endocrinol Metabol. 2012;14(3):241-247.

    Not in our library

37. 37.

    Shirani S, Heidari K, Sabzghabaee AM, Mirmoghtadaee P, Hoseini L, Aalifar H, Aalifar H, Fadaei H, Esnaashari H, Soltani R. The modifiable noncommunicable risk factors among an Iranian population. Southeast Asian J Tropical Med Public Health. 2012;43(5):1227.

    Not in our library

38. 38.

    Lankarani KB, Ghaffarpasand F, Mahmoodi M, Lotfi M, Zamiri N, Heydari ST, Fallahzadeh MK, Maharlouei N, Babaeinejad M, Mehravar S, Geramizadeh B. Non alcoholic fatty liver disease in southern Iran: a population based study. Hepatitis. 2013;13(5):6.

    Not in our library10.5812/hepatmon.9248

39. 39.

    Dastgiri S, Mahdavi R, TuTunchi H, Faramarzi E. Prevalence of obesity, food choices and socio-economic status: a cross-sectional study in the north-west of Iran. Public Health Nutr. 2006;9(08):996-1000.

    Not in our library10.1017/phn2006982

40. 40.

    Yarahmadi S, Etemad K, Hazaveh AM, Azhang N. Urbanization and non-communicable risk factors in the capital city of 6 big provinces of iran. Iranian J Public Health. 2013;42(Supple1):113.

    Not in our library

Cited by papers we hold 6

• Disparities in Obesity Prevalence in Iranian Adults: Cross-Sectional Study Using Data from the 2016 STEPS Survey · 2021
  Not checked
• Prevalence of modifiable cardiovascular risk factors in Yazd inner-city municipalities · 2020
  Not checked
• Patterns of Obesity and Overweight in the Iranian Population: Findings of STEPs 2016 · 2020
  No notice
• Obesity in Iran: Challenges Arising and Policy Options · 2019
  Not checked
• A Study on the Knowledge, Attitude, and Practices of Iranian Mothers towards Childhood Obesity · 2019
  Not checked
• Overweight and obesity epidemic in Ghana—a systematic review and meta-analysis · 2016
  No notice

Reads

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.